Healthcare · Biotechnology · NASDAQ
| Market cap | $3.18B |
|---|---|
| Trailing P/E | 120.4 |
| FCF yield | -0.5% |
| Revenue growth (YoY) | +91.3% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Arcutis Biotherapeutics, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Jun 5, 2026 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | May 3, 2023 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Jul 8, 2022 |